2023 was a tricky calendar year for the biopharma industry, with quite a few corporations downsizing and restructuring their workforces to remain afloat. You will discover indications of Restoration, as mergers and acquisitions picked up across the pharmaceutical and lifetime sciences industry within the latter Section of 2023 and also https://sites.google.com/view/bio-sites/blog